CSIMarket Company Name, Ticker, Industry, else..
 
Obseva Sa  (NASDAQ: OBSV)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Obseva SA is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for women's reproductive health. The company is involved in the research, development, and production of drugs targeting conditions such as endometriosis, uterine fibroids, and preterm labor. Obseva aims to address the unmet medical needs of women and improve their quality of life through its products and treatments. The company utilizes advanced scientific and clinical expertise to develop safe and effective therapies, with a commitment to improving women's reproductive health worldwide.


   Company Address: Chemin des Aulx, 12 Geneva 1228
   Company Phone Number: 22 552 38 40   Stock Exchange / Ticker: NASDAQ OBSV


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

ObsEva Provides Board of Directors Update and Geneva Court Grants Temporary Moratorium

Published Tue, Mar 19 2024 6:00 AM UTC

In a recent update, ObsEva, a leading biopharmaceutical company focused on women s reproductive health, announced changes to its Board of Directors. These developments, along with a subsequent court ruling, have significant implications for the company s future operations.ObsEva revealed that effective immediately, three new members have joined its Board of Directors. These ...
Announcement

Navigating Uncertainty: ObsEva's Wind-Down and the Challenges of Establishing Audited IFRS Financial Statements

Published Wed, Feb 28 2024 6:00 AM UTC

TITLE: ObsEva Announces Wind-Down of Operations and Potential Effects on 2023 Audited IFRS Financial StatementsINTRODUCTIONIn an ad hoc announcement pursuant to 53 LR of the SIX Swiss Exchange, ObsEva, a biopharmaceutical company specializing in the development of innovative therapies for reproductive health and pregnancy-related conditions, has disclosed its decision to wi...
Announcement

ObsEva's Phoenix Moment: A Temporary Moratorium Illuminates the Path to Success

Published Wed, Jan 31 2024 6:00 AM UTC

Title of the Geneva Court s Temporary Moratorium Provides Hope for ObsEva s Future SuccessIn recent news, the Geneva Court has granted ObsEva, a Swiss biopharmaceutical company specialized in women s reproductive health, a temporary moratorium. This legal development, pursuant to Art. 53 LR of the SIX Swiss Exchange, has significant implications for ObsEva s future operatio...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio -
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.